查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1499564

肺癌手術市場：按手術設備、手術程序和最終用戶分類 - 全球預測 2024-2030 年

Lung Cancer Surgery Market by Surgical Devices (Endo Surgical Equipment, Monitoring & Visualizing Systems, Surgical Instruments), Surgical Procedures (Minimally Invasive Surgeries, Thoracotomy), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年肺癌手術市場規模為56.9億美元，預計2024年將達60.1億美元，2030年將達85億美元，複合年成長率為5.88%。

肺癌手術是一種旨在透過切除肺部惡性和病變組織來治療肺癌的醫療程序。當癌症局限於肺部的一個區域並且尚未廣泛擴散到身體的其他部位時，通常會使用這種手術干預。肺癌手術的主要目標是根除全部或大部分癌細胞，從而治癒患者，或至少顯著延長患者的生命並提高患者的生活品質。由於肺癌是全世界最常見的癌症之一，對有效手術介入的需求不斷增加。這種不斷上升的盛行率將透過增加對切除或縮小腫瘤的專門外科手術的需求來顯著促進肺癌手術，最終迫使醫療保健系統適應，我們鼓勵他們提供這些必要的服務。此外，各國政府也實施了有利的政策，促進創新手術設備和技術的核准流程。這些支持措施將有助於更快地將有效、安全的治療方法推向市場，並擴大肺癌的治療選擇。然而，肺癌手術的高成本以及手術程序的標準化有限，構成了阻礙市場擴張的重大挑戰。此外，微創手術技術和機器人輔助手術的發展取得了重大進展，為領先公司提供了新的途徑。先進的機器人和人工智慧可以提高手術精度、減少人為錯誤並改善術後效果。

主要市場統計
基準年[2023] 56.9億美元
預測年份 [2024] 60.1億美元
預測年份 [2030] 85億美元
複合年成長率（%） 5.88%

區域洞察

在美洲，美國和加拿大在肺癌盛行率和肺癌手術創新方面都佔據重要地位。該地區擁有高度發展的醫療保健系統和較高的年度醫療支出，可以輕鬆獲得先進的外科治療。患者意識和高保險覆蓋率正在推動視訊輔助胸腔鏡手術 (VATS) 和機器人手術等微創手術的需求。該地區最近的專利通常側重於增強這些微創手術並改善手術結果。同時，歐洲、中東和非洲國家展示了強大的政府支持的醫療保健系統，並積極參與肺癌研究網路。歐盟對醫療技術和研究的投資，例如地平線 2020 計劃，對肺癌的手術技術和結果有直接影響。提供先進外科護理的全民健保系統進一步支持病患的治療效果。此外，亞太地區肺癌患者數量正在顯著增加。導致這一成長的因素包括某些國家的高吸煙率、都市區的空氣污染以及人口的遺傳傾向。發病率的增加推動了對有效肺癌治療和手術的需求。亞太地區許多國家正積極加強醫療基礎設施和能力。日本、韓國、澳洲和中國等國家正在醫療保健領域進行大量投資，包括現代化醫療設施以及培訓專門從事腫瘤學和胸腔外科的醫療專業人員。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在肺癌手術市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對肺癌手術市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在肺癌手術市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 肺癌發生率上升和吸菸趨勢增加
      • 癌症的早期診斷和治療變得越來越重要
      • 更多採用微創技術
    • 抑制因素
      • 肺癌診療費用高昂
    • 機會
      • 肺癌治療技術進展
      • 癌症治療的報銷政策與政府支持
    • 任務
      • 缺乏訓練有素的專業人員
  • 市場區隔分析
    • 手術設備：監測和可視化系統的技術進步可改善複雜的肺癌手術過程
    • 手術：肺癌微創手術因其減輕疼痛和恢復更快的優點而越來越受到青睞。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章肺癌手術市場手術設備

  • 末端手術設備
  • 監控及視覺化系統
  • 手術器械

第7章依手術方式分類的肺癌手術市場

  • 微創手術
  • 開胸手術

第8章肺癌手術市場：依最終用戶分類

  • 醫院
  • 專業癌症治療中心

第9章北美及南美肺癌手術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肺癌手術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲肺癌手術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 諾華收購 Mariana Oncology 增強癌症治療能力
    • Harmonic 臨床試驗的擴展，東亞非吸菸者非小細胞肺癌治療的新領域
    • 開創性的移植計畫為第四期肺癌患者帶來新的生命
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-501246436957

[187 Pages Report] The Lung Cancer Surgery Market size was estimated at USD 5.69 billion in 2023 and expected to reach USD 6.01 billion in 2024, at a CAGR 5.88% to reach USD 8.50 billion by 2030.

Lung cancer surgery is a medical procedure aimed at treating lung cancer by removing malignant tumors and affected tissues from the lungs. This surgical intervention is typically employed when the cancer is localized in one area of the lung and has not extensively spread to other parts of the body. The primary goal of lung cancer surgery is to eradicate all or most of the cancerous cells, potentially leading to a cure or at least a significant extension of lifespan and improvement in the quality of life of the patient. As lung cancer remains one of the most common types of cancer worldwide, the demand for effective surgical interventions continues to grow. This rise in prevalence significantly drives lung cancer surgery by increasing the need for specialized surgical procedures aimed at removing or reducing tumors, ultimately pushing healthcare systems to adapt and provide these necessary services. In addition, governments in various countries have been implementing favorable policies that expedite the approval process of innovative surgical devices and techniques. These supportive measures ensure that effective and safe tools reach the market sooner, facilitating enhanced treatment options for lung cancer. However, the high cost associated with lung cancer surgeries, along with the limited standardization during surgery procedures, is a significant challenge hindering market expansion. Moreover, significant progress in the development of minimally invasive surgical techniques and robotic-assisted surgery presents new avenues for key companies. Advanced robotics and artificial intelligence can improve precision in surgery, reduce human errors, and improve postoperative outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 5.69 billion
Estimated Year [2024] USD 6.01 billion
Forecast Year [2030] USD 8.50 billion
CAGR (%) 5.88%

Regional Insights

In the Americas, the United States and Canada are significant in both the prevalence of lung cancer and innovations in lung cancer surgery. The region's highly developed healthcare system and significant annual healthcare spending facilitate access to advanced surgical treatments. Patient awareness and high insurance coverage drive demand for minimally invasive surgeries, such as video-assisted thoracoscopic surgery (VATS) and robotic surgery. Recent patents in the region often focus on enhancing these minimally invasive techniques and improving surgical outcomes. At the same time, EMEA countries exhibit strong government-supported healthcare systems and active participation in lung cancer research networks. The EU's investment in health technology and research, such as the Horizon 2020 program, directly impacts lung cancer surgical techniques and outcomes. Patient outcomes are further supported by universal healthcare coverage, which provides access to advanced surgical care. Moreover, the Asia Pacific region has seen a significant uptick in the number of lung cancer cases. Factors contributing to this rise include high smoking rates in certain countries, urban air pollution, and genetic predispositions among populations. This increasing incidence has driven the demand for effective lung cancer treatments and surgeries. Many countries within the Asia Pacific region have been actively enhancing their healthcare infrastructures and capabilities. Nations such as Japan, South Korea, Australia, and China have made significant investments in healthcare, including modernizing medical facilities and training healthcare professionals specializing in oncology and thoracic surgery.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Lung Cancer Surgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • Increasing emphasis on early diagnosis & treatment of cancers
      • Growing adoption of minimally invasive techniques
    • Market Restraints
      • High cost of lung cancer diagnosis & treatments
    • Market Opportunities
      • Rising technological advancements in lung cancer treatment
      • Availability of reimbursements policies and government support for cancer treatments
    • Market Challenges
      • Shortage of trained professionals
  • Market Segmentation Analysis
    • Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Lung Cancer Surgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Lung Cancer Surgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology

Novartis has significantly advanced its position in the field of oncology by acquiring Mariana Oncology, a pioneering biotech firm based in Watertown, Massachusetts. This strategic move enriches Novartis' portfolio with innovative radioligand therapies (RLTs) targeting cancers that are notably difficult to treat. This acquisition enhances Novartis' research infrastructure and clinical supply capabilities and also aligns with its strategic priorities focusing on oncology and the innovation of its RLT platforms. [Published On: 2024-05-02]

Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia

Lantern Pharma has recently obtained regulatory approval to broaden the scope of its Phase II Harmonic clinical trial into Japan and Taiwan to evaluate LP-300, an innovative drug candidate, in combination with standard chemotherapy treatments pemetrexed and carboplatin for non-small cell lung cancer (NSCLC). This trial promises to fast-track the development and potential approval of LP-300 and also aligns with global efforts to provide targeted cancer therapies tailored to genetic profiles and demographic-specific risk factors. [Published On: 2024-04-23]

Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients

In an innovative clinical initiative, Northwestern Medicine has launched the Double Lung Replacement and Multidisciplinary Care (DREAM) program, offering new hope through double-lung transplants for select stage 4 lung cancer patients whose disease is confined to the lungs and who have exhausted other treatment options. DREAM program transforms and extends lives through its focused, multidisciplinary approach as lung cancer remains the most lethal of cancers in the United States. [Published On: 2023-03-15]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Lung Cancer Surgery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Surgery Market, highlighting leading vendors and their innovative profiles. These include Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter Healthcare Corporation, FusionKraft Surgical Instruments, Henry Schein, Inc., Intuitive Surgical Inc., Johnson & Johnson Services, Inc., KARL STORZ GmbH, Key Surgical LLC by STERIS plc, KLS Martin Group, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Richard Wolf GmbH, Scanlan International Inc., Siemens Healthineers AG, Sontec Instruments Inc., Teleflex Incorporated, TROKAMED GmbH, and Wexler Surgical Inc..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Surgical Devices
    • Endo Surgical Equipment
    • Monitoring & Visualizing Systems
      • Cameras & Video Support
      • Endoscopic Trocars with Optical Views
    • Surgical Instruments
      • Hand Instruments
        • Clamps
        • Cutters
        • Elevators
        • Foreceps
        • Retractors
        • Rib Shears
        • Scissors
        • Staplers
        • Trocar
      • Powered Surgical Equipment
  • Surgical Procedures
    • Minimally Invasive Surgeries
    • Thoracotomy
      • Lobectomy
      • Pneumenectomy
      • Segmentectomy
      • Sleeve Resection
  • End-user
    • Hospitals
    • Specialized Cancer Treatment Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of lung cancer coupled with growing trend of smoking tobacco
      • 5.1.1.2. Increasing emphasis on early diagnosis & treatment of cancers
      • 5.1.1.3. Growing adoption of minimally invasive techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of lung cancer diagnosis & treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancements in lung cancer treatment
      • 5.1.3.2. Availability of reimbursements policies and government support for cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Surgical Devices: Technological advancements in the monitoring and visualizing systems to enhance the complex surgery procedures of lung cancer
    • 5.2.2. Surgical Procedures: Growing preference for minimally invasive surgeries in lung cancer due to their adventages in reducing pain and fast recovery
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Lung Cancer Surgery Market, by Surgical Devices

  • 6.1. Introduction
  • 6.2. Endo Surgical Equipment
  • 6.3. Monitoring & Visualizing Systems
  • 6.4. Surgical Instruments

7. Lung Cancer Surgery Market, by Surgical Procedures

  • 7.1. Introduction
  • 7.2. Minimally Invasive Surgeries
  • 7.3. Thoracotomy

8. Lung Cancer Surgery Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialized Cancer Treatment Centers

9. Americas Lung Cancer Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Lung Cancer Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Lung Cancer Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Novartis Enhances Cancer Treatment Capabilities with Acquisition of Mariana Oncology
    • 12.3.2. Expansion of Harmonic Clinical Trial, A New Frontier in NSCLC Treatment for Never-Smokers in East Asia
    • 12.3.3. Pioneering Transplant Program Offers New Lease on Life for Stage 4 Lung Cancer Patients
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. LUNG CANCER SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. LUNG CANCER SURGERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDO SURGICAL EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CAMERAS & VIDEO SUPPORT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CLAMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CUTTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELEVATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY FORECEPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY RIB SHEARS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY TROCAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED SURGICAL EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LOBECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PNEUMENECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SEGMENTECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SLEEVE RESECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SPECIALIZED CANCER TREATMENT CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY HAND INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL PROCEDURES, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY THORACOTOMY, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND LUNG CANCER SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM LUNG CANCER SURGERY MARKET SIZE, BY MONITORING & VISUALIZING SYSTEMS, 2018-2023 (USD MI